Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Type I interferons play a key role in the development of various skin diseases.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata treatment varies, with no optimal method established yet.

NF-κB is crucial for zebrafish heart repair, affecting heart cell growth and repair processes.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.